Combined management in the treatment of epidoxorubicin extravasation. A case report.
Inadvertent extravasation during intravenous antitumor therapy is not an unusual complication and can cause damage ranging from minor erythema to severe local necrosis. The appropriate management of these iatrogenic accidents as a part of supportive care in oncology has been addressed by several experimental studies, but there has been little clinical study and no conclusive evidence on the best therapeutic strategies to adopt. The case reported here of a patient suffering from severe soft-tissue injury caused by extravasation of epidoxorubicin demonstrates the usefulness of a combined management (medical, surgical and rehabilitative) in the appropriate care of extravasation.
Dini
D
D
Cancer Rehabilitation Department, National Institute for Cancer Research, Genova, Italy.
Forno
G
G
Gozza
A
A
Silvestro
S
S
Bertelli
G
G
Toma
S
S
Filippi
F
F
Passarelli
B
B
D000368:Aged; D003131:Combined Modality Therapy; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D015251:Epirubicin / Q000009:adverse effects*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D007262:Infusions, Intravenous / Q000009:adverse effects; D017695:Soft Tissue Injuries / Q000139:chemically induced / Q000628:therapy*
D015251:Epirubicin; D004121:Dimethyl Sulfoxide